ARTICLE | Financial News
Lysogene completes IPO
February 10, 2017 9:50 PM UTC
Gene therapy company Lysogene S.A. (Euronext:LYS) raised €22.6 million ($24.3 million) through the sale of 3.3 million shares at €6.80 in an IPO underwritten by Société Générale and Gilbert Dupont on...
BCIQ Company Profiles